Filing Overview
This Form 8-K was filed by Tivic Health Systems, Inc. on January 26, 2024, reporting an event effective January 22, 2024. The provided request metadata identifies the company as Valion Bio, Inc., which does not match the registrant named in the filing. Tivic Health Systems is incorporated in Delaware and its common stock trades on Nasdaq under “TIVC.”
Material Management Change
- Ryan Sabia was terminated immediately as an employee and Chief Operating Officer on January 22, 2024.
- His executive offer letter dated April 1, 2022, referred to as the Sabia Employment Agreement, terminated concurrently.
- The company stated that the termination was not related to its financial or operating results and did not result from disagreements or concerns about financial or reporting practices.
- Mr. Sabia is not entitled to severance. He will receive salary and benefits earned through January 22, 2024.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, guidance, or other quantitative financial information.
Outlook, Risks, and Unusual Items
The filing provides no management guidance or broader business outlook. The principal disclosed event is the immediate termination of the Chief Operating Officer and termination of his employment agreement. No severance obligation was reported.
Investor Verification Items
- Confirm the correct issuer: the filing names Tivic Health Systems, Inc., while the request metadata names Valion Bio, Inc.
- Verify whether a replacement Chief Operating Officer was appointed in a subsequent filing.
- Review subsequent reports for any operational, compensation, or governance effects associated with the termination.
- Confirm that accrued salary and benefits through January 22, 2024 were the only payments due to Mr. Sabia.